BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31214734)

  • 1. Prognostic factors in patients with T1 glottic cancer treated with radiotherapy.
    Mucha-Małecka A; Chrostowska A; Urbanek K; Małecki K
    Strahlenther Onkol; 2019 Sep; 195(9):792-804. PubMed ID: 31214734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
    Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in elderly patients with T1 glottic cancer treated with radiotherapy.
    Mucha-Małecka A; Małecki K; Amrogowicz N; Biesaga B; Modrzejewski M
    Sci Rep; 2021 Sep; 11(1):17717. PubMed ID: 34489495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifactorial analysis of local control and survival in patients with early glottic cancer.
    Nomura T; Ishikawa J; Ohki M; Ohata A; Araki R; Kikuchi S
    Laryngoscope; 2020 Jul; 130(7):1701-1706. PubMed ID: 31397901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiation therapy in glottic laryngeal carcinoma stage. I. Results and analysis of prognostic factors].
    Skołyszewski J; Reinfuss M; Kowalska T; Walasek T; Dymek P
    Otolaryngol Pol; 1996; 50(3):243-7. PubMed ID: 9045160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Impact of Initial Therapy in Patients with T1-T2 Glottic Squamous Cell Carcinoma.
    Brady JS; Marchiano E; Kam D; Baredes S; Eloy JA; Park RC
    Otolaryngol Head Neck Surg; 2016 Aug; 155(2):257-64. PubMed ID: 27026735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.
    Khan MK; Koyfman SA; Hunter GK; Reddy CA; Saxton JP
    Radiat Oncol; 2012 Nov; 7():193. PubMed ID: 23164282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy in glottic T1 carcinoma. Local control and survival].
    Herranz J; Fernández M; Ramos S; Vázquez Barro C; Sarandeses García A; Martínez Vidal J; Veiras C
    Acta Otorrinolaringol Esp; 2000; 51(1):57-61. PubMed ID: 10799934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.
    Salas-Salas BG; Domínguez-Nuez DJ; Cabrera R; Ferrera-Alayón L; Lloret M; Lara PC
    Clin Transl Oncol; 2020 Jan; 22(1):151-157. PubMed ID: 31152306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma?
    Brouha XD; Op De Coul B; Terhaard CH; Hordijk GJ
    Clin Otolaryngol Allied Sci; 2000 Jun; 25(3):215-8. PubMed ID: 10944052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between 4-MV and 6-MV radiotherapy in T1N0 glottic cancer.
    Sommat K; Yit NL; Kwok LL
    Laryngoscope; 2017 May; 127(5):1061-1067. PubMed ID: 27237064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of local failure in early laryngeal cancer.
    Lohynska R; Slavicek A; Bahanan A; Novakova P
    Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T1 glottic carcinoma involving the posterior commissure.
    Shvero J; Shvili I; Mizrachi A; Shpitzer T; Nageris B; Koren R; Hadar T
    Laryngoscope; 2009 Jun; 119(6):1116-9. PubMed ID: 19308987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive radiotherapy for T1 glottic squamous cell carcinoma: a 15-year Cruces University Hospital experience.
    Cacicedo J; Casquero F; del Hoyo O; Gomez-Iturriaga A; Martinez-Indart L; Lopez JL; Bilbao P
    Clin Transl Oncol; 2013 Nov; 15(11):925-31. PubMed ID: 23519536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy Of Medical Sciences.
    Jin J; Liao Z; Gao L; Huang X; Xu G
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):471-8. PubMed ID: 12243824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1 squamous cell carcinoma of the glottis with anterior commissure involvement: Radiotherapy versus transoral laser microsurgery.
    Alkan U; Nachalon Y; Shkedy Y; Yaniv D; Shvero J; Popovtzer A
    Head Neck; 2017 Jun; 39(6):1101-1105. PubMed ID: 28371063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer.
    Reddy SP; Mohideen N; Marra S; Marks JE
    Radiother Oncol; 1998 May; 47(2):161-6. PubMed ID: 9683364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.